136 related articles for article (PubMed ID: 20017662)
1. Various drug delivery approaches to the central nervous system.
Pasha S; Gupta K
Expert Opin Drug Deliv; 2010 Jan; 7(1):113-35. PubMed ID: 20017662
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa.
Masand G; Hanif K; Sen S; Ahsan A; Maiti S; Pasha S
Brain Res Bull; 2006 Jan; 68(5):329-34. PubMed ID: 16377439
[TBL] [Abstract][Full Text] [Related]
3. Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.
Stenehjem DD; Hartz AM; Bauer B; Anderson GW
Future Med Chem; 2009 Dec; 1(9):1623-41. PubMed ID: 21425983
[TBL] [Abstract][Full Text] [Related]
4. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery to the central nervous system: a review.
Misra A; Ganesh S; Shahiwala A; Shah SP
J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
[TBL] [Abstract][Full Text] [Related]
6. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.
Campbell M; Ozaki E; Humphries P
Expert Opin Drug Deliv; 2010 Jul; 7(7):859-69. PubMed ID: 20486860
[TBL] [Abstract][Full Text] [Related]
8. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
9. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
11. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
Ganta S; Deshpande D; Korde A; Amiji M
Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive effect of novel chimeric peptides of met-enkephalin and FMRFa.
Hanif K; Fahim M; Pavar MC; Bansal V; Pasha S
Regul Pept; 2005 Feb; 125(1-3):155-61. PubMed ID: 15582727
[TBL] [Abstract][Full Text] [Related]
13. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
15. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
20. Chimeric peptide of met-enkephalin and FMRFa: effect of chlorination on conformation and analgesia.
Hanif K; Gupta K; Gupta S; Gupta YK; Maiti S; Pasha S
Neurosci Lett; 2006 Jul; 403(1-2):131-5. PubMed ID: 16764989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
